Versartis, Inc.·4

May 2, 5:24 PM ET

Versartis, Inc. 4

4 · Versartis, Inc. · Filed May 2, 2016

Insider Transaction Report

Form 4
Period: 2016-04-04
Hislop Colin
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-04-04+223,100223,100 total
    Exercise: $8.17Exp: 2026-04-03Common Stock (223,100 underlying)
Footnotes (1)
  • [F1]1/4th of the total number of shares subject to the option shall vest on the first yearly anniversary of the vesting commencement date and 1/36th of the remaining number of shares subject to the option shall vest on each monthly anniversary of the vesting commencement date thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION